Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$0.45 - $1.95
Next Earnings Date
May 13 2025
Next Earnings Date
May 13 2025
Latest price
Market Cap | $49.73M |
EV | $-0.11B |
Shares Outstanding | 82.69M |
Beta | 1.64 |
Analyst Rating | BUY |
Analyst Target Price | $6.40 |
P/E 2025E | - |
P/Revenue 2025E | 10.46x |
Revenue | - |
EPS | 12.70% |
Operating Cash Flow | -22.30% |
Free Cash Flow | -13.70% |
Revenue | - |
EPS | 22.10% |
Operating Cash Flow | 6.90% |
Free Cash Flow | - |
Gross Margin 2025E | - |
Net Profit Margin 2025E | - |
ROE 2025E | - |
ROCE 2024 | -65.65% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Adicet Bio, Inc.
ACET
Sector
Healthcare
Industry
Biotechnology
CEO
Schor, Chen
Employees
152
Website
www.adicetbio.comIPO Date
2018-01-26
Headquarters
131 Dartmouth Street, 3rd Floor, Boston, Massachusetts, 02116, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved